Perrigo Stock Analysis (NYSE:PRGO)

Add to My Stocks
$71.93 $1.14 (1.56%) PRGO stock closing price May 24, 2017 (Closing)
Watch Robo Advisor Video of PRGO Stock Analysis
Perrigo
Updated on : May 24, 2017
previous close
PRGO 71.9 (0%)
S&P 500 2404.4 (0%)
Closing Price On: May 24, 2017
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical Products
Sector :
Medical
5 Quarter Revenue
Revenue Growth
2016-Q3
$billion
%
YOY GROWTH
Compared to the industry
Operating Profit
Operating Margin:
-46.5%
Sector Average:
1.1%
5 Quarter Net Profit
Net Margins
2016-Q3
%
LTM Margin
Debt/Equity Ratio
Debt:
5.64B
Debt/Equity Ratio:
 0.65
Compared to the industry
Cash Flow
Operating cash flow:
$303.9M
Net Income:
-$1.26B
PROS      CONS
FCF Margin
Operating Margins
Net Margins
High Debt Burden
ROIC
ROE
Rating: ★★★★★★★★★★ (0/5)
Other Metrics
Return on Invested Capital:
-12.7%
Return on Equity:
-15.3%
Free Cash Flow Margin:
20.4%
Double Tap To Exit Full Screen
0:00
/

Perrigo Analysis Video

287 5 2

View Perrigo stock analysis video. This is our PRGO analyst opinion covering the buy and sell arguments for PRGO stock.

Perrigo Company plc Ordinary Shares Stock Rating (2.6/5)

Our Perrigo stock opinion is based on fundamentals of the company. This Perrigo stock analysis is based on latest Q3 earnings for 2016. The stock price analysis takes into account a company's valuation metrics.

Should you buy PRGO stock?

  • The company has a good Free Cash Flow (FCF) margin of 20.4%.

Should you sell PRGO stock?

  • Over the last twelve months, Perrigo posted an average operating loss margin of -46.5%.
  • Perrigo registered an average TTM Net loss of -26.6%.
  • With a debt/equity ratio of  0.65, Perrigo is highly leveraged in comparison to Medical peers.
  • Perrigo's negative ROIC of -12.7% indicates operational inefficiency.
  • Perrigo has a negative ROE (Return On Equity) of -15.3%, indicating the company is not profitable.

Comments on this video and Perrigo stock

Related to Perrigo Company plc Ordinary Shares Analysis